Trials / Terminated
TerminatedNCT00685750
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
Analysis of the Expression of a Specific Set of Genes and Tumor Antigens in Patients With Non-small Cell Lung Cancer or Melanoma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to analyze the expression of specific sets of markers in tumor samples and in serum from patients with Non-Small Cell lung Cancer (NSCLC) or Stage III or IV melanoma. The data obtained in this study will be used to guide future development of immunotherapies for melanoma or NSCLC patients. Moreover, the analyses will contribute to definition of markers potentially predictive of clinical response to specific anticancer therapies.
Detailed description
This protocol posting has been updated due to a protocol amendment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Collection of tumor and blood samples | Samples will be collected before and after standard treatment |
Timeline
- Start date
- 2008-04-28
- Primary completion
- 2013-12-17
- Completion
- 2013-12-17
- First posted
- 2008-05-28
- Last updated
- 2019-06-20
- Results posted
- 2019-06-20
Locations
34 sites across 5 countries: United States, France, Germany, Italy, Sweden
Source: ClinicalTrials.gov record NCT00685750. Inclusion in this directory is not an endorsement.